NCT04013386View on ClinicalTrials.gov

Effects of Aprepitant/Dexamethasone Versus Mertazepine /Dexamethasone on Postoperative Nausea and Vomiting

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

July 15, 2019

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Nausea and Vomiting, Postoperative
Interventions
DRUG

Aprepitant and Dexamethasone

Aprepitant capsule 80 mg and Dexamethasone 8 mg IVI

DRUG

Mirtazapine and Dexamethasone

Mirtazapine tablet 30 mg and Dexamethasone 8 mg IVI

DRUG

Dexamethasone

Dexamethasone 8 mg IVI

Trial Locations (1)

Unknown

Ain-Shams University Hospitals, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT04013386 - Effects of Aprepitant/Dexamethasone Versus Mertazepine /Dexamethasone on Postoperative Nausea and Vomiting | Biotech Hunter | Biotech Hunter